CXCR4 and infection: In this study, we demonstrate that TIQ-15 is a novel tetrahydroisoquinolines-based CXCR4 antagonist that restricts Gαi-based SDF-1 signaling, thereby blocking HIV-1 entry and infection (Table 3).